Novilytic is a molecular recognition company that utilizes nanotechnology to monitor the quality of lifesaving medicines.
Novilytic has raised $531K in total funding. The most recent round was Undisclosed. The last funding was announced in December 2025.
Novilytic's investors include Elevate Ventures, Purdue Foundry, Stateline Angels.
Novilytic is headquartered in West Lafayette, United States.
Novilytic is a molecular recognition company that utilizes nanotechnology to monitor the quality of lifesaving medicines.
Novilytic is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Novilytic — Funding & Investors." VCBacked, December 15, 2025, https://www.vcbacked.co/company/novilytic. Accessed November 13, 2026.
VCBacked. (2025). Novilytic — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/novilytic
{{cite web |title=Novilytic — Funding & Investors |url=https://www.vcbacked.co/company/novilytic |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Novilytic? Request a listing update